Clinical Trial Update: TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

View source ↗

Summary

This clinical trials update reports on a completed study evaluating transarterial chemoembolization (TACE) in combination with PD-1/PD-L1 inhibitors and targete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhongda Hospital | Conditions: Hepatocellular Carcinoma | Status: COMPLETED